Enterolactone is a mammalian lignan metabolite formed through intestinal microbial metabolism of dietary lignans found in flaxseeds, sesame seeds, whole grains, legumes, and berries. It is produced from precursor lignans including secoisolariciresinol and matairesinol after digestion and microbial transformation.
Enterolactone functions mainly as a lignan-derived polyphenolic metabolite involved in oxidative stress modulation, microbiome-associated signaling interactions, estrogen receptor-related pathways, and cellular redox regulation. Research has explored its effects on antioxidant systems, inflammatory mediators, endothelial responses, and endocrine-associated signaling pathways.
Circulating enterolactone levels can vary substantially between individuals depending on gut microbiome composition and dietary intake.
Plants synthesize lignan precursors through phenylpropanoid biosynthesis pathways derived from aromatic amino acid metabolism. Following ingestion, intestinal microbiota metabolize lignans through sequential enzymatic reactions that ultimately produce enterolactone.
Flaxseeds are among the richest dietary sources of lignan precursors. Whole grains, berries, legumes, and seeds also contribute significantly.
After microbial formation, enterolactone undergoes absorption, hepatic conjugation, circulation, and elimination through detoxification pathways.
Enterolactone activity is regulated by microbiome composition, dietary fiber intake, intestinal metabolism, hepatic conjugation, and oxidative environment. Individual microbial diversity strongly influences production efficiency.
Research suggests enterolactone may interact with oxidative stress pathways, estrogen receptor-associated systems, inflammatory mediators, endothelial signaling, and mitochondrial responses. Biological effects depend on concentration, metabolism, and tissue localization.
Consumption of lignan-rich foods including flaxseeds, sesame seeds, berries, and whole grains supports enterolactone formation together with additional microbial metabolites that collectively contribute to antioxidant and microbiome-associated signaling diversity.
| Inhibitor / Factor | Effect on Activity / Absorption |
|---|---|
| Antibiotic use and low fiber reduce exposure. |
